Skip to content

STOP (Shared Decision Making to Treat Or Prevent) HIV in Justice Populations

STOP (Shared Decision Making to Treat Or Prevent) HIV in Justice Populations

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06439329
Enrollment
40
Registered
2024-06-03
Start date
2024-10-03
Completion date
2025-03-31
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorders

Brief summary

This study seeks to compare the effectiveness of two Patient Navigation models of care to evaluate the proportion who initiate PrEP/ART and substance use/substance use disorder (SU/SUD) treatment. A standardized Patient Navigation (PN) arm will be compared with a shared decision-making model in the form of Patient Choice (PC) through the offer of a menu of existing community-based health service delivery options. This design will offer providers, correctional and public health authorities, payers and policy makers' timely and relevant data to assess the effectiveness of Patient Navigation and Patient Choice models of care as potentially useful re-entry and relapse prevention treatment options.

Detailed description

This study will be done in two phases. Phase 1 the R61 portion of the project will be a Pilot Study, and Phase 2 the R33 portion of the project will be a Randomized Controlled Trail informed by the pilot (NCT07223398). The focus of this registration is the pilot study. In Year 1 (R61; Aim 1) the intervention of the patient choice menu of options of PrEP/ART and SUD treatment services for justice involved people who use drugs (PWUD) to supplement established peer navigation (PN +PC) will be developed and pilot tested in Western Connecticut only (Fairfield, Litchfield, Southern New Haven Counties). Implementation procedures for this study include needs assessment survey and focus groups consisting of CAB members and PNs to assess the types of services available in their community, as well as gaps in services and ideas of how services can be improved. These needs assessment surveys and focus groups will occur 3 times throughout the study.

Interventions

BEHAVIORALStandard PN

Standard of care

BEHAVIORALPatient Choice

Participants can select from a menu of options including brick and mortar services, Mobile Health Unit (MHU) or telehealth services.

Sponsors

Yale University
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* able to provide written informed consent in English or Spanish; * living in the community of Western, CT, Dallas and Tarrant Counties in TX and Madison County, KY (potential for Fayette county as well); * Those with current justice involvement (with in the past 6 months) (e.g., prison, jail, community supervision); * willing to have HIV testing to determine negative or positive status; * persons with HIV who report not currently taking ART and have a viral load \>200 copies/mL in past 6 months OR persons who test negative for HIV who report not taking PrEP that meet CDC PrEP eligibility criteria in past 6 months, including (i) condomless sexual intercourse; and/or (ii) sharing IDU equipment with HIV positive or unknown status partner; and/or (iii) bacterial STI and; * Having a history of opioid and/or stimulant use within 12 months prior to being in a controlled setting and/or in the last 6 months within the community Implementation portion/CAB members: * able to provide written informed consent in English or Spanish; * working with persons with a history of justice involvement and substance use in the areas targeted for this project PN Participants: * able to provide written informed consent in English or Spanish; * be employed at a project research site as a Patient Navigator

Exclusion criteria

* severe medical or psychiatric disability making participation unsafe; * unable to provide consent. * persons self-reporting pregnancy Implementation portion/CAB members: * persons self-reporting pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Feasibility/Acceptability Will be Assessed Using the CAB Community Needs Assessment3 monthsAttitudes toward acceptability and feasibility of the PN and PN+PC menu of options will be surveyed from CAB members using the needs assessment created during project ACTION as a foundation. Total score range is 5-20 for each category. Higher scores indicate increased acceptability, appropriateness, and feasibility. Assessed only in CAB members.
Feasibility/Acceptability Will be Assessed Using the Organizational Readiness for Implementing Change (ORIC) From the JCOIN Common Measure Survey3 monthsOrganizational readiness for implementing change (ORIC) will be surveyed at start of preparation and sustainment phases with CAB members to evaluate confidence and commitment to using the PN+PC approach. Total scores range from 12 to 60, with higher scores indicating greater readiness. This survey was administered to CAB members only.
Mean Score for Participant Attitudes Toward the Interventions Will be Assessed Using the Scales for Participant Alliance With Recovery Coach (SPARC)3 monthsParticipant attitudes toward the PN and PN+PC implementation approach (rapport, satisfaction, linkage to services, engagement) will be collected at 3 months using the Scales for Participant Alliance with Recovery Coach; SPARC. The SPARC is scored on a Likert scale (1 = strongly disagree to 5 = strongly agree), higher scores indicate a high perception of the recovery coach alliance. There are six domains (engagement, satisfaction, rapport, motivation and encouragement, role model, and community linkage), and each domain score is between 10 and 50.
Number of Participants That Utilized Access of PrEP/ART Services3 monthsUtilization of Services and PN Engagement data will be used to assess the number of participants that utilized access of PrEP/ART services.
Number of Participants With Receipt of Treatment3 monthsDefined as participants that have received a prescription for PrEP/ART

Secondary

MeasureTime frameDescription
Substance Use Treatment3 monthsNumber of participants engaged in substance use disorder (SUD) treatment

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSandra Springer, MD

Yale University

Participant flow

Pre-assignment details

32 participants signed consent but one was lost to follow up prior to randomization. 31 patient participants were randomized.

Baseline characteristics

Characteristic
Age, Continuous48 years
Education
1 or more years of college credit, but no degree
0 Participants
Education
Associate's Degree (e.g., AA or AS)
2 Participants
Education
Bachelor's degree
1 Participants
Education
Did not complete high school
0 Participants
Education
GED or equivalent
8 Participants
Education
Graduate degree (MSW, MA, MS, JD, MD, DSW, EdD, Ph.D, etc.)
3 Participants
Education
Regular high school diploma
1 Participants
Education
Some college credit, but less than 1 year of college credit
2 Participants
Education
Trade School
0 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
8 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
28 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
Had Insurance, last 30 days15 Participants
Hepatitis C (HCV) Rapid Testing Results
Non-Reactive
8 Participants
Hepatitis C (HCV) Rapid Testing Results
Previous HCV diagnosis
2 Participants
Hepatitis C (HCV) Rapid Testing Results
Reactive
1 Participants
HIV Rapid Testing Results
Non-Reactive
15 Participants
HIV Rapid Testing Results
Previous HIV diagnosis
1 Participants
HIV Rapid Testing Results
Reactive
0 Participants
Housing
In a shelter
1 Participants
Housing
Other residential facility or institution (e.g. healthcare facility, halfway house)
1 Participants
Housing
Rent an apartment /house
9 Participants
Housing
Staying with family/ friends
3 Participants
Housing
Transitional ( time-limited) single room occupancy
3 Participants
Housing
Unhoused
5 Participants
Injection Drug Use, last 30 days3 Participants
Participants with Moderate to Severe Substance Use Disorder Diagnoses by Substance
Alcohol
3 Participants
Participants with Moderate to Severe Substance Use Disorder Diagnoses by Substance
Opioids
18 Participants
Participants with Moderate to Severe Substance Use Disorder Diagnoses by Substance
Stimulants
21 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
7 Participants
Race (NIH/OMB)
More than one race
2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
Race (NIH/OMB)
White
19 Participants
Received public assistance, last 12 months12 Participants
Region of Enrollment
United States
15 participants
Self-perceived HIV risk
High risk
3 Participants
Self-perceived HIV risk
Living with HIV
1 Participants
Self-perceived HIV risk
Low risk
7 Participants
Self-perceived HIV risk
Medium risk
2 Participants
Self-perceived HIV risk
No response
0 Participants
Self-perceived HIV risk
No risk
6 Participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 161 / 15
other
Total, other adverse events
3 / 160 / 15
serious
Total, serious adverse events
1 / 160 / 15

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026